| 2019 | A Phase I/II, Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of Lower Doses of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: The KMM103 Study | 문영철 | Article |
| 2010 | Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: Results of the Korean Multiple Myeloma Working Party (KMMWP) | 성주명 | Article |
| 2014 | Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: Web-based multicenter registry study | 문영철 | Article |
| 2012 | Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL) | 문영철 | Article |
| 2009 | Clinical features and survival outcomes in patients with multiple myeloma: Analysis of web-based data from the korean myeloma registry | 문영철 | Article |
| 2021 | Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone | 문영철 | Article |
| 2013 | Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantation | 문영철 | Article |
| 2017 | Improved prognostic stratification using NCCN- and GELTAMOinternational prognostic index in patients with diffuse large B-cell lymphoma | 문영철 | Article |
| 2014 | Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea - Experience from 110 patients | 문영철 | Article |
| 2018 | Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150) | 문영철 | Article |
| 2012 | VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large b cell lymphoma | 정화순; 문영철 | Article |
